Modeling spinal muscular atrophy in Drosophila.
Spinal Muscular Atrophy (SMA), a recessive hereditary neurodegenerative disease in humans, has been linked to mutations in the survival motor neuron (SMN) gene. SMA patients display early onset lethality coupled with motor neuron loss and skeletal muscle atrophy. We used Drosophila, which encodes a single SMN ortholog, survival motor neuron (Smn), to model SMA, since reduction of Smn function leads to defects that mimic the SMA pathology in humans. Here we show that a normal neuromuscular junction (NMJ) structure depends on SMN expression and that SMN concentrates in the post-synaptic NMJ regions. We conducted a screen for genetic modifiers of an Smn phenotype using the Exelixis collection of transposon-induced mutations, which affects approximately 50% of the Drosophila genome. This screen resulted in the recovery of 27 modifiers, thereby expanding the genetic circuitry of Smn to include several genes not previously known to be associated with this locus. Among the identified modifiers was wishful thinking (wit), a type II BMP receptor, which was shown to alter the Smn NMJ phenotype. Further characterization of two additional members of the BMP signaling pathway, Mothers against dpp (Mad) and Daughters against dpp (Dad), also modify the Smn NMJ phenotype. The NMJ defects caused by loss of Smn function can be ameliorated by increasing BMP signals, suggesting that increased BMP activity in SMA patients may help to alleviate symptoms of the disease. These results confirm that our genetic approach is likely to identify bona fide modulators of SMN activity, especially regarding its role at the neuromuscular junction, and as a consequence, may identify putative SMA therapeutic targets.
Chang
Howard Chia-Hao
HC
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States of America.
Dimlich
Douglas N
DN
Yokokura
Takakazu
T
Mukherjee
Ashim
A
Kankel
Mark W
MW
Sen
Anindya
A
Sridhar
Vasanthi
V
Fulga
Tudor A
TA
Hart
Anne C
AC
Van Vactor
David
D
Artavanis-Tsakonas
Spyros
S
D000483:Alleles; D017398:Alternative Splicing; D000818:Animals; D004331:Drosophila melanogaster; D006801:Humans; D008954:Models, Biological; D008957:Models, Genetic; D018482:Muscle, Skeletal / Q000378:metabolism; D009134:Muscular Atrophy, Spinal / Q000235:genetics* / Q000473:pathology*; D009154:Mutation; D009469:Neuromuscular Junction / Q000473:pathology; D009474:Neurons / Q000378:metabolism; D010641:Phenotype; D034622:RNA Interference; D013569:Synapses / Q000378:metabolism
Nat Genet. 1997 Jul;16(3):265-9
9207792
Neuron. 2002 Feb 14;33(4):545-58
11856529
Trends Cell Biol. 2002 Oct;12(10):472-8
12441251
Trends Cell Biol. 2007 Jul;17(7):343-52
17644382
Hum Mol Genet. 2006 Feb 1;15(3):511-8
16396995
Cold Spring Harb Symp Quant Biol. 2006;71:313-20
17381311
Am J Hum Genet. 2002 Feb;70(2):358-68
11791208
Nat Genet. 2000 Jan;24(1):66-70
10615130
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6307-11
10339583
Neuron. 2002 Feb 14;33(4):529-43
11856528
Hum Mol Genet. 2008 Apr 1;17(7):949-62
18065780
J Cell Biol. 2003 Nov 24;163(4):801-12
14623865
PLoS One. 2007 Sep 26;2(9):e921
17895963
Development. 1998 Oct;125(20):3977-87
9735359
J Clin Invest. 2007 Mar;117(3):659-71
17318264
Neuron. 2002 Oct 24;36(3):403-16
12408844
Mol Cell Biol. 2005 Jul;25(13):5543-51
15964810
Cell. 2008 May 16;133(4):585-600
18485868
Nature. 2007 Jul 12;448(7150):151-6
17625558
Nature. 1997 Oct 9;389(6651):627-31
9335506
Development. 1993 Aug;118(4):1077-88
8269841
Hum Mol Genet. 2008 Aug 15;17(16):2552-69
18492800
Mol Cell Biol. 2002 Sep;22(18):6533-41
12192051
Am J Hum Genet. 1997 Jun;60(6):1411-22
9199562
Neuron. 2005 Sep 1;47(5):695-708
16129399
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7841-6
16682643
Cell. 1995 Jan 13;80(1):155-65
7813012
Neuron. 2003 Jul 17;39(2):241-54
12873382
Hum Mol Genet. 1999 Jul;8(7):1177-83
10369862
Hum Mol Genet. 2003 Jun 15;12(12):1367-76
12783845
Curr Opin Cell Biol. 2002 Jun;14(3):305-12
12067652
Curr Opin Genet Dev. 2002 Jun;12(3):294-8
12076672
Hum Mol Genet. 2000 Feb 12;9(3):333-9
10655541
Development. 1994 Apr;120(4):755-68
7600955
Neuron. 1994 Oct;13(4):823-35
7946331
EMBO J. 2007 Jun 6;26(11):2621-32
17491591
Neuron. 1997 Nov;19(5):1007-16
9390515
Cell. 1993 Sep 24;74(6):1125-34
8104705
Am J Hum Genet. 2008 Apr;82(4):834-48
18371932
Nat Genet. 2004 Mar;36(3):288-92
14981519
PLoS One. 2008 Jan 02;3(1):e1404
18167563
Nat Genet. 2004 Mar;36(3):283-7
14981521
FEBS Lett. 2000 Dec 8;486(2):99-102
11113446
Curr Biol. 2004 Oct 26;14(20):1863-70
15498496
J Cell Biol. 2007 Mar 12;176(6):831-41
17353360
J Neurosci. 1993 Nov;13(11):4924-35
8229205
Dev Biol. 1988 Apr;126(2):294-303
3127258
Hum Mol Genet. 2008 Apr 15;17(8):1063-75
18178576
Neuron. 2005 Dec 22;48(6):885-96
16364894
Science. 2008 Apr 25;320(5875):524-7
18440926
Mol Cell. 2000 Jan;5(1):59-71
10678169
J Cell Biol. 2003 Sep 1;162(5):919-31
12952942
Neurobiol Dis. 1996 Apr;3(2):97-110
9173917
Development. 1998 Jul;125(14):2723-34
9636086
J Neurosci. 1999 Apr 15;19(8):3023-32
10191319
Hum Mutat. 2000;15(3):228-37
10679938
Development. 1993 Jun;118(2):401-15
8223268
Nat Med. 2007 Feb;13(2):204-10
17237794
Genetics. 2007 Dec;177(4):2493-505
18073442
Mol Biol Cell. 1998 Aug;9(8):2145-56
9693372
Trends Genet. 2000 Jan;16(1):27-33
10637628
Neuron. 2006 Feb 16;49(4):517-31
16476662
J Cell Biol. 2006 Mar 13;172(6):875-84
16533947
Lancet. 2006 Aug 5;368(9534):489-504
16890836
EMBO J. 1996 Jul 15;15(14):3555-65
8670859
Trends Mol Med. 2006 Mar;12(3):113-21
16473550